196 related articles for article (PubMed ID: 34040390)
1. Comprehensive Analysis of the Relationship Between Metabolic Reprogramming and Immune Function in Prostate Cancer.
Xie W; Guo H; Zhang J; Hu L; Wu Y; Wang X
Onco Targets Ther; 2021; 14():3251-3266. PubMed ID: 34040390
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the association between tumor glycolysis and immune/inflammation function in breast cancer.
Li W; Xu M; Li Y; Huang Z; Zhou J; Zhao Q; Le K; Dong F; Wan C; Yi P
J Transl Med; 2020 Feb; 18(1):92. PubMed ID: 32070368
[TBL] [Abstract][Full Text] [Related]
3. Lactate Transporter SLC16A3 (MCT4) as an Onco-Immunological Biomarker Associating Tumor Microenvironment and Immune Responses in Lung Cancer.
Tao Q; Li X; Zhu T; Ge X; Gong S; Guo J; Ma R
Int J Gen Med; 2022; 15():4465-4474. PubMed ID: 35509603
[TBL] [Abstract][Full Text] [Related]
4. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
5. Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration.
Zhang Y; Zhu B; Cai Y; Zhu S; Zhao H; Ying X; Jiang C; Zeng J
BMC Cancer; 2022 Jan; 22(1):2. PubMed ID: 34980012
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer.
Yu J; Liu TT; Liang LL; Liu J; Cai HQ; Zeng J; Wang TT; Li J; Xiu L; Li N; Wu LY
Cancer Cell Int; 2021 Jul; 21(1):353. PubMed ID: 34229669
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms, immune cell infiltration, and potential drugs for prostate cancer.
Yan Y; Mao X; Zhang Q; Ye Y; Dai Y; Bao M; Zeng Y; Huang R; Mo Z
Cancer Biomark; 2021; 31(1):87-96. PubMed ID: 33780364
[TBL] [Abstract][Full Text] [Related]
8. SNAP25 is a potential prognostic biomarker for prostate cancer.
Di L; Gu M; Wu Y; Liu G; Zhang L; Li Y; Zhang W
Cancer Cell Int; 2022 Apr; 22(1):144. PubMed ID: 35392903
[TBL] [Abstract][Full Text] [Related]
9. Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
Takahashi H; Kawabata-Iwakawa R; Ida S; Mito I; Tada H; Chikamatsu K
Sci Rep; 2021 Sep; 11(1):17789. PubMed ID: 34493792
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming.
Yu T; Liu Z; Tao Q; Xu X; Li X; Li Y; Chen M; Liu R; Chen D; Wu M; Yu J
Cancer Lett; 2024 May; 589():216824. PubMed ID: 38522774
[TBL] [Abstract][Full Text] [Related]
11. Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis.
Wang G; Liu X; Wang D; Sun M; Yang Q
Front Oncol; 2021; 11():636565. PubMed ID: 33842342
[No Abstract] [Full Text] [Related]
12. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a novel glycolysis-related prognostic gene signature for ovarian cancer and its relationships with immune infiltration of the tumor microenvironment.
Bi J; Bi F; Pan X; Yang Q
J Transl Med; 2021 Sep; 19(1):382. PubMed ID: 34496868
[TBL] [Abstract][Full Text] [Related]
14. MYBL2 is a Novel Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Prostate Cancer.
Jiao M; Zhang F; Teng W; Zhou C
Int J Gen Med; 2022; 15():3003-3030. PubMed ID: 35313552
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics analysis of expression and prognostic value of NSUN members in prostate cancer.
Sun G; Ma S; Zheng Z; Wang X; Chen S; Chang T; Liang Z; Jiang Y; Xu S; Liu R
Front Oncol; 2022; 12():965571. PubMed ID: 35978830
[TBL] [Abstract][Full Text] [Related]
16. Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures.
Huo C; Zhang MY; Li R; Liu TT; Li JP; Qu YQ
Front Cell Dev Biol; 2021; 9():645482. PubMed ID: 34368114
[TBL] [Abstract][Full Text] [Related]
17. Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma.
Song W; He X; Gong P; Yang Y; Huang S; Zeng Y; Wei L; Zhang J
Front Genet; 2021; 12():639246. PubMed ID: 34249078
[No Abstract] [Full Text] [Related]
18.
Wang C; Wang J; Chen S; Li K; Wan S; Yang L
Curr Cancer Drug Targets; 2024; 24(3):340-353. PubMed ID: 37592784
[TBL] [Abstract][Full Text] [Related]
19. Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment.
Jiang Z; Liu Z; Li M; Chen C; Wang X
EBioMedicine; 2019 Apr; 42():431-442. PubMed ID: 30935888
[TBL] [Abstract][Full Text] [Related]
20. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
